Management & Administration

Canada’s Health Agency Mismanages Millions in Medical Assets
Management & Administration Canada’s Health Agency Mismanages Millions in Medical Assets

The National Emergency Strategic Stockpile represents a critical pillar of Canada's readiness against unforeseen health crises, yet recent disclosures from the Public Health Agency of Canada suggest a disturbing trend of administrative negligence and physical asset degradation. This specific

Carbon Health Settles California Case Over Deceptive Billing
Management & Administration Carbon Health Settles California Case Over Deceptive Billing

The recent settlement involving Carbon Health and California authorities underscores the critical importance of transparent financial practices within the rapidly evolving landscape of modern urgent care providers. As healthcare delivery models transition toward hybrid digital-first environments,

Can New Jersey Protect Reproductive and Transgender Care?
Management & Administration Can New Jersey Protect Reproductive and Transgender Care?

The landscape of American healthcare is currently undergoing a seismic shift as state governments grapple with the consequences of fragmented judicial rulings that vary wildly across geographic borders. In response to this increasingly complex environment, New Jersey has asserted its legislative

Nepal Battles Rising Dengue Cases Across 71 Districts
Management & Administration Nepal Battles Rising Dengue Cases Across 71 Districts

The rapid expansion of dengue fever across the mountainous and lowland regions of Nepal has reached a critical threshold, signaling a profound shift in the nation's public health landscape. In just the first half of the current year, the Epidemiology and Disease Control Division has documented the

Is Managed Medicaid the Right Model for Nursing Home Care?
Management & Administration Is Managed Medicaid the Right Model for Nursing Home Care?

The landscape of long-term care financing is currently undergoing a radical transformation as state legislatures grapple with the escalating costs of providing essential services to an aging population. For decades, the traditional Fee-for-Service model reigned supreme, but the recent pivot toward

How Will Federal Policy Reshape US Drug Pricing by 2026?
Management & Administration How Will Federal Policy Reshape US Drug Pricing by 2026?

The longstanding paradigm of American pharmaceutical economics has been fundamentally dismantled as the federal government fully transitions from a passive payer into an active price setter for the most expensive medications on the market. This shift represents the culmination of a multi-year

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later